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Abstract 
Background: Development of alternative cancer‑specific drugs would be of paramount importance to overcome 
toxicity toward normal tissues and tumor resistance. Here, we investigated the potential anti‑tumoral effect of peel 
(Peph) and pulp polyphenolic extracts from the Tunisian quince Cydonia oblonga Miller on both no‑tumorigenic cells 
NIH 3T3 Fibroblasts and HEK 293 cells and human colon adenocarcinoma LS174 cells.
Methods: Cell proliferation and cytotoxicity were measured with MTT and LDH assays respectively. Cell cycle distri‑
bution and the apoptosis levels were assessed by flow cytometry. Intracellular reactive oxygen species (ROS) levels 
were determined using the fluorescent probe CM‑H2DCFDA. Western blot was used to further characterize cell death 
and analyze the signaling pathways affected by Peph treatment. The expression level of VEGF‑A was evaluated by real 
time quantitative PCR and further verified by quantifying the secreted cytokines by enzyme‑linked immunosorbent 
assay.
Results: We found that Peph extract displayed the highest anti‑proliferative effect specifically on LS174 cells. How‑
ever, each Peph phenolic compound alone did not exhibit any anti‑proliferative activity, suggesting a synergistic 
effect of phenolic molecules. Such effect was associated with a cell cycle arrest in the G1/S phase, a caspase‑inde‑
pendent apoptosis and an increase of the ROS production. Peph extract inhibited the pro‑survival signaling pathway 
NFκB and suppressed the expression of various cellular markers known to be involved in cell cycling (cyclin D1) 
and angiogenesis (Vascular Endothelial Growth Factor, VEGF). Interestingly, the combination Peph extract and 5‑FU 
exerted synergistic inhibitory effect on cell viability.
Conclusion: These data propose the quince Peph extract as a promising cost effective non toxic drug to employ 
alone or in combination with conventional anti‑colorectal cancer. Moreover, quince rich regimen may prevent the 
development and the progress of colon cancer.
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Background
Colorectal cancer (CRC) is the second most fatal and the 
third most diagnosed type of cancer worldwide. Despite 
having multifactorial causes, most CRC cases are mainly 
determined by dietary factors [1]. Nutrition has been 
estimated to cause more than one-third of cancer deaths, 
and that dietary factors are responsible for 70–90 % of all 
cases [2].
Plants have proved to be an important source of 
anti-cancer drugs [3]. Polyphenols are secondary 
metabolites widely present in plant kingdom that play 
promising role in cancer prevention and therapy [4]. Sev-
eral studies using cancer cell lines and animal models of 
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carcinogenesis have shown that a wide range of polyphe-
nols possess anticancer properties including initiation of 
apoptosis through the regulation of cell death pathways, 
the suppression of cancer cell proliferation and metasta-
sis through inhibition of anti-apoptotic molecules, and 
cell cycle arrest [5]. Although polyphenols are generally 
recognized as antioxidants, they also act as prooxidants 
inducing growth arrest and cell death through increasing 
ROS production [6].
The most important signaling pathways regulating cell 
proliferation and survival implicated in colorectal cancer 
involve Wnt/β-catenin, phosphatidyl-inositol-3-kinase 
(PI3  K), growth factor receptors/Ras/mitogen-activated 
protein kinases (MAPK), JAKs/STAT3 and especially 
nuclear factor κB (NF-κB) [7]. Induction of NF-κB tran-
scription factor, caused by extracellular stimuli, passes 
through IκB kinase α (IKKα) and/or IKKβ activation [8]. 
The phosphorylation of IκB inhibitory proteins by IKK 
activated complex induces ubiquitination and degrada-
tion of the IκBs. The dissociated NF-κB complex relo-
cates to the nucleus where it binds to DNA promoter 
region and activates genes involved in several cellular 
activities like cell growth, survival, angiogenesis, migra-
tion and metastasis [9]. Two major target genes of NF-κB, 
cell cycle cyclin D1 and Vascular Endothelial Growth 
Factor (VEGF), are known to play a vital role in tumor 
progression [10]. This perfectly correlates with the fact 
that inhibition of NFκB activity in colorectal cancer cells 
dramatically reduces cell growth in vitro and in vivo [11].
Considering this, several dietary natural phytochemi-
cal compounds have been found to be potent inhibi-
tors of NF-κB pathway with anticarcinogenic properties 
[12]. Cydonia oblonga Miller (quince) is recognized as a 
good and low-cost natural source of different classes of 
phenolic compounds responsible for its anti-oxidant, 
anti-ulcerative and anti-microbial activity [13, 14]. We 
have previously showed that quince peel polyphenols 
have a potent anti-inflammatory effect in LPS-stimulated 
human macrophages and that such effect pass through 
inhibition of NF-κB activation [15]. Moreover, quince 
polyphenols were reported to present antiproliferative 
activity in human cancer cells [16]. Notwithstanding 
these various studies, the anti-tumor effect with mecha-
nisms of action of Cydonia oblonga Miller has never 
been assessed. Here, we investigated the anti-colon can-
cer activity of polyphenolic extract from the Tunisian 
quince (Cydonia oblonga Miller). We found that both 
quince peel polyphenolic extract (Peph) and pulp poly-
phenolic extract (Puph) inhibits viability of human colon 
adenocarcinoma LS174 cells. However, Peph present the 
most potent antitumor effect through the blocking of cell 
growth and the induction of apoptosis and a cell cycle 
arrest accompanied with an increase of reactive oxygen 
species (ROS) production. Moreover, Peph extract signif-
icantly enhances the anti-cancer effect of 5-fluorouracil. 
This study suggests that Cydonia oblonga Miller phenolic 
extract may have therapeutic applications for colon can-
cer treatment and that a quince rich regimen may pre-
vent the development and the progress of colon cancer.
Results
Quince polyphenols inhibit human colon cancer LS174 
cells viability
To investigate whether the polyphenolic extracts from the 
peel (Peph) and pulp (Puph) of quince Cydonia oblonga 
Miller [13] exhibit anti-tumor activites, MTT assay was 
employed to assess their effects on cell viability in LS174 
colon adenocarcinoma cells. Interestingly, we found that 
increasing concentrations (1–20  µg/ml) of Peph and 
Puph polyphenolic extracts significantly reduced viabil-
ity of LS174 cells in a dose-dependent manner after 72 h 
exposure (Fig.  1a). However, at concentrations higher 
than 5 µg/ml, the antiproliferative effects on LS174 cells 
were accompanied by a concomitant increase in LDH 
activity and cell toxicity (over 70 % of LDH leakage com-
pared to positive control (100 % toxicity, Triton 1 %), as 
shown by LDH assay (Fig. 1b). Thus, for further investi-
gation, we have chosen the concentration of 5  µg/ml of 
quince polyphenols that did not affect the viability of 
non-tumorigenic cells, the NIH 3T3 Fibroblasts and HEK 
293 cells (Fig. 1a) and that caused more than 50 % inhi-
bition of LS174 cell viability without any measured cell 
toxicity. We next followed the kinetic, over 3 days, of the 
inhibitory effect of 5  µg/ml of Peph and Puph phenolic 
extracts, on LS174 cell viability. As shown in Fig. 2a, both 
polyphenolic fractions induced a time-dependent cancer 
cell growth decrease with an inhibitory effect of Peph 
extract significantly higher (70  %) than the one exerted 
by Puph extract (48 %). Analysis of the phenolic composi-
tion of each extract has also revealed that phenolic con-
tent in the Peph is three times higher than the one of the 
Puph (Fig. 2b).
Quince peel polyphenolic extract inhibited‑growth 
of LS174 cells involves total phenolic molecules
In order to identify the active phenolic compounds 
behind the antiproliferative effect of Peph polyphenolic 
extract, the effects of its thirteen phenolic constituents 
were evaluated against the human tumourigenic colon 
cell line, LS174. All compounds where tested at equiva-
lent concentrations to that present in 5 µg/ml of the total 
peel polyphenolic extract. Surprisingly, at this concentra-
tion, each phenolic compound failed alone to induce sig-
nificant effect on LS174 cell viability (Table 1). Moreover, 
we found no significant inhibitory effect, on LS174 cells 
growth, when we tested the 78 possible combinations 
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of two isolated phenolic compounds (Table 2). We have 
further extended our analysis to assess the effect of 200 
combinations of three compounds or more. However, we 
did not succeed to reconstitute the effect obtained with 
the whole Peph extract (Additional file 1: Figure S1), sug-
gesting that the Peph-inhibited proliferation of LS174 
cells relies on the synergetic effect of the total polyphe-
nolic molecules.
Quince peel polyphenols cause G1 phase cell cycle arrest 
and inhibit the expression of cell‑cycle regulator cyclin D1 
in LS174 cells
A major event leading to carcinogenesis is the disrup-
tion of cell division cycle control through the dysregula-
tion of cell cycle regulatory proteins [17]. In accordance 
with this, we explored the effect of Peph treatment on 
the cell cycle phase distribution of LS174 cells. As shown 
in Fig. 3a, treatment of the cells for 24 h with 5 µg/ml of 
Peph increased sub-G0 population (from 7 to 22.9  %) 
indicating apoptotic population. Accumulation of cells 
in G1 phase (from 40 to 46.37 %) was accompanied with 
a decrease in the S phase population (from 22 to 15 %). 
Within 72 h of treatment, Peph induced cell cycle pertur-
bation and accumulation of 41 % of cells in sub-G0 phase. 
Since cyclin D1 protein is an important regulator of cell 
cycle progression from the G1-phase to the S-phase, we 
investigated its expression level during treatment of the 
cells with 5  µg/ml of Peph extract. The results showed 
that the expression level of cyclin D1 was reduced 
(Fig. 3b), suggesting its involvement in the Peph-induced 
LS174 cell cycle perturbation.
Quince peel polyphenols induce a caspase‑independent 
apoptosis of LS174 cells
The increase of the sub-G0 population after Peph treat-
ment (Fig. 3a) along with the typical apoptotic morpho-
logical changes (nuclear fragmentation and membranes 
blebbing) observed by microscopy (data not shown) 
suggest that the decreased LS174 cell viability was 
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Fig. 1 Cydonia oblonga Miller polyphenolic extract reduces LS174 cell viability in a dose‑dependent manner. a Non‑tumourigenic cells HEK293, 
NIH 3T3 and Human colon adenocarcinoma LS174 cells were treated for 72 h with increasing concentrations (1–20 µg/ml) of Cydonia oblonga 
Miller peel (Peph) and pulp (Puph) polyphenolic extract. Cell viability was determined by MTT assay. b LDH release from HEK293, NIH 3T3 and LS174 
cells was determined by using the LDH assay after 72 h of treatment with different concentrations (5–20 µg/ml) of Peph and Puph. Results were 
normalized to each control in percentage and represented as mean ± SE of three independent experiments, each performed at least in triplicate. 
Statistical differences were analyzed with Student’s t test (*p < 0.05 as compared to the control, ns: non significant)
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showed an increase of the percentage of annexin-V pos-
itive cells (43.7 %) after 24 h of treatment with 5 µg/ml 
of peel polyphenolic extract. The percentage of apop-
totic cells increased to 54  % after 72  h of treatment, 
supporting the induction of cells death (Fig.  3c). To 
further explore the mechanism by which Peph extract 
induced cell apoptosis, we examined the caspases activ-
ity by western blotting. As showed in Fig.  3d, the peel 
polyphenols-induced apoptosis was not associated with 
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Fig. 2 The phenolic profile of Peph and Puph extracts and their effects on LS174 cell viability. a Cell viability of LS174 cells treated with 5 µg/ml of 
quince polyphenolic extracts (Peph and Puph) for 72 h was determined by MTT assay. b Each phenolic compound in peel and pulp was identified 
and quantified using high‑performance liquid chromatography with diode‑array detection (HPLC–DAD) coupled on line to a mass spectrometer 
(MS). Based on a concentration [mg/100 g of the fresh weight (fw)] and combination of retention time and spectral matching of compounds, the 
percentage (%) of each phenolic molecule was calculated
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caspase-3 substrate, PARP, was not cleaved in Peph-
treated cells, suggesting that Peph induced a caspases-
independent apoptosis of LS174 cells. To better verify 
this result, Z-VAD-fmk, a universal pan-caspase inhibi-
tor, was added to the medium along with Peph. As 
shown in Fig.  3c, the caspase inhibitor did not reduce 
Peph-induced apoptosis while it diminished the cell 
death induced by the positive control, staurosporin (St). 
The apoptotic inducing factor (AIF), is considered as 
the main molecular effector and mediator of caspase-
independent apoptosis [18]. Interestingly, we found that 
the treatment of the cells by the Peph extract increased 
the expression of AIF protein (Fig.  3e). These results 
suggest that the antiproliferative effect exerted by the 
quince peel phenolic extract passes through the induc-
tion of AIF, leading to caspase-independent apoptosis of 
the treated cells.
Quince peel polyphenols induce ROS production
It is well established that the reactive oxygen species 
(ROS) could cause cell apoptosis [19]. We thus assessed 
the effect of Peph extract on the intracellular redox sta-
tus of LS174 cells after 24 and 72  h of treatment. Pre-
treatment of LS174 cells with 5  µg/ml of Peph extract 
increased the level of ROS compared to mock-treated 
cells (Fig.  3f ), suggesting their involvement in Peph-
induced apoptosis of LS174 cells.
Quince peel polyphenols‑induced apoptosis is associated 
with the inhibition of NF‑κB activity
To further characterize the mechanisms by which peel 
polyphenols inhibited cell growth, induced apoptosis 
and arrested cell cycle progression, we tested the involve-
ment of MAPK (JNK, p38, and ERK1/2) cascades, PI3K/
AKT and NF-κB signaling pathway that play critical role 
in colorectal cancer [20]. As shown in Fig.  4, the peel 
extract suppressed the NFκB activation as demonstrated 
by the inhibition of IkB kinase (IKK) phosphorylation 
(Fig.  4), suggesting the involvement of such pathway in 
Peph effects. However, we revealed no interference with 
the activity of the other studied kinases such as ERK1/2, 
p38 MAPK, SAPK/JNK and AKT in Peph-treated-LS174 
(Fig. 4).
Quince peel polyphenols inhibit the expression of the 
angiogenic effector VEGF‑A
A high level of the potent angiogenic factor VEGF has 
been shown to be associated with colon cancer progres-
sion [21]. Since, VEGF expression is directly regulated 
by the NF-κB transcription factor [22], we assessed the 
effect of Peph extract-mediated inhibition of NF-κB on 
the angiogenic mediator VEGF-A.
The levels of mRNA and proteins encoding for VEGF 
were examined by real-time qPCR and ELISA analysis 
in mock and Peph-treated LS174 cells. We found that 
VEGF-A expression was significantly reduced in Peph-
treated cells at both the mRNA and protein levels (Fig. 5). 
This data suggest an additional potential anti-angiogenic 
activity of peel polyphenols through the inhibition of 
VEGF expression.
Quince peel polyphenols markedly reduce tumor cell 
colony formation and potentiate the effect of 5‑fluorouracil 
chemotherapy
To further investigate the anti-tumoral effect of quince 
peel polyphenolic extract and to test its long-term effect, 
we analyzed the impact of such extract on cancer colony 
formation along with its effect when combined to 5-FU, 
the conventional drug used in chemotherapy of epithelial 
solid tumors. We first found that treatment of cells with 
Peph extract alone had similar anti-tumor growth effect 
as the one exhibited by 5-FU, as shown by the decrease 
of viable colonies compared to non-treated cells (Fig. 6). 
Combined treatment of 5-FU with Peph extract caused 
more decrease in colony formation of cancer cells com-
pared to 5-FU alone. These results showed that 5 µg/ml of 
Peph extract produced a strong anti-tumor activity when 
combined with 50 µM of 5-FU, indicating that Peph and 
5-FU has synergistic anti-tumor effects on LS174 cells.
Discussion
We have previously reported a potent anti-inflammatory 
effect of quince (Cydonia oblonga Miller) peel polyphe-
nolic extract in LPS-stimulated human THP-1-derived 
macrophages [15]. Accumulating evidence shows that 
Table 1 Effect of  Peph phenolic compounds on  prolifera-
tion of LS174 cells compared to total Peph extract
Treatment Cell viability (%)
None 100 ± 3
Quercetin (Q) 100 ± 4
Rutin (R) 90 ± 1.3
(+)‑Catechin (+C) 97 ± 4
(−)‑Catechin (−C) 89 ± 3.9
Hyperin (H) 99 ± 3
Isoquercitrin (I) 91 ± 4
Chlorogenic acid (ChA) 93 ± 1
Cryptochlorogenic acid (CrA) 100 ± 4
Neochlorogenic acid (NeA) 94 ± 3.3
P‑coumaric acid (PcA) 90 ± 1.97
Kaempferol (K) 100 ± 3.2
Kaempferol‑3‑O‑glucoside (K3g) 100 ± 1.2
Kaempferol‑3‑O‑rutinoside (K3r) 97 ± 2.4
Peph 26 ± 1.3
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chronic inflammation is an important etiologic factor in 
the development of colorectal cancer [23] and several 
studies have shown that dietary polyphenols with anti-
inflammatory properties are effective against different 
types of cancer [24]. Our aim was to investigate the anti-
colon cancer effect of a non toxic natural extract from 
quince as an alternative to treat and prevent the growth 
and development of colorectal cancer. In this work we 
show, for the first time, that peel polyphenolic extract 
of Cydonia oblonga Miller goes further than an anti-
proliferative agent in colon cancer cells, displaying pro-
apoptotic and anti-angiogenic activities along with the 
capacity to enhance chemotherapeutic effectiveness of 
5-fluorouracil.
We first found that the Tunisian quince (Cydonia 
oblonga Miller) aqueous acetone extract presented a 
dose-dependent inhibition effect on the viability of 







Fig. 3 Quince peel polyphenolic extract induces cell cycle arrest, caspase‑independent apoptosis and ROS generation in LS174 cells. a Histogram 
analysis of the cell cycle phases in mock‑ and treated‑LS174 cells with 5 µg/ml of Peph for 24 and 72 h by flow cytometry using propidium iodide 
assay. b Quince peel polyphenolic extract down‑regulates the expression level of cyclin D1 protein. Whole cell lysates (30 µg), from LS174 cells 
treated with Peph (5 µg/ml) or vehicle for 24–72 h, were resolved on SDS‑PAGE gel and probed with the indicated antibody for western blot analy‑
sis. β‑actin was used as a control for equal loading. c Flow cytometry analysis using annexin V/7‑AAD staining of Z‑VAD‑FMK (20 µM)‑pretreated 
LS174 cells cultured in the absence (control) and presence of 5 µg/ml of Peph extract for 24 and 72 h. Annexin V/7AAD double staining discrimi‑
nates the live cells (Annexin V−/7AAD−; bottom left quadrant), early apoptotic cells (Annexin V+/7AAD−; bottom right quadrant), late apoptotic 
or necrotic cells (Annexin V+/7AAD+; upper right quadrant), and dead cells (Annexin V−/7AAD+; upper left quadrant). d Compared to the positive 
control (Staurosporine), western blot analysis showed the absence of caspase 3, 9 activities in LS174 cells after incubation for 72 h with Peph extract. 
e Induction of caspase‑independent pathways mediated by the increase of apoptosis‑inducing factor AIF proteins after treatment by quince Peph 
extract. f ROS production was measured with CMH2DCFDA staining after 24 and 72 h of treatment with 5 µg/ml of peel polyphenolic extract. Fluo‑
rescence was used to detect ROS as described in “Methods”. The data are representative of three independent experiments. Data are reported as the 
mean ± SE of three separate experiments (*p < 0.05)
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observed in the non-tumorigenic cells. Our data indi-
cate that the peel polyphenolic extract inhibited the 
proliferation of human LS174 colon cancer cells with-
out any toxic effect, as assessed with LDH assay. This 
correlates with previous work done by Carvalho et  al. 
[16] that reported an inhibition effect of the methanolic 
extract of Cydonia oblonga Miller on the proliferation of 

















Fig. 4 Quince peel polyphenolic extract blocks the activation of NF‑κB. LS174 cells were treated with vehicle or with Peph (5 µg/ml) for 24, 48 and 
72 h. Protein extracts (30 µg) prepared were analyzed by western blotting using the indicated antibodies. β‑actin was used as a loading control. 
Data are representative of three independent experiments
Fig. 5 Peel polyphenolic extract inhibits VEGF‑A expression in human colon cancer LS174 cells. LS174 cells were treated with vehicle or Peph (5 µg/
ml) for 72 h. a The amount of VEGF‑A mRNA transcript was quantified by real time PCR. The values are normalized to 36B4 and the control value was 
taken as 100 %. b Supernatants from LS174 cultured in the absence (vehicle) or presence of Peph (5 µg/ml) were collected and analyzed by Human 
VEGF specific ELISA. Results are reported as the mean ± SE of three independent experiments each run in triplicate (*p < 0.05). The data were cor‑
rected to the cell number
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quince peel polyphenols (Peph) presented higher anti-
proliferative effect than those extracted from the pulp 
(Puph). This might be explained by the difference in the 
phenolic composition of each extract. Indeed, according 
to the results we previously reported [13, 15], total phe-
nolic content of the pulp and peel parts of quince (Cydo-
nia oblonga Miller) extracts ranged from 37 to 47 and 
105 to 157  mg/100  g of fresh weight, respectively. Phe-
nolic components level in the peel fraction is three times 
higher than the one of the pulp. Phytochemical inves-
tigations led to the identification of thirteen phenolic 
compounds in quince Peph extract [13]. Previous stud-
ies highlighted the anti-cancer properties of the isolated 
phenolic molecules in tumor cells. Chlorogenic acid, a 
phenolic molecule found in the quince peel polyphenolic 
extract, has been reported to induce apoptotic cell death 
in U937 leukemia cells [25]. Rutin, another major compo-
nent of the peel quince polyphenolic extract (36 %), has 
been also reported to exert antitumoral effects in human 
colon cancer cells [26]. Moreover, quercetin and kaemp-
ferol, additional members of the quince peel polyphenols, 
effectively inhibits pancreatic tumour growth in vitro and 
in vivo via an increase in apoptosis [27]. All the remain-
ing components of the peel quince polyphenolic extract 
like catechin and procyanidin have revealed promising 
chemopreventive and/or anticancer efficacy in several 
Fig. 6 Quince peel polyphenols markedly reduce tumor cell colony formation and potentiates 5‑fluorouracil efficacy. Peph effect on LS174 colony‑
forming capacity was measured using clonogenic survival assay. LS174 cells were treated with vehicle (control) or Peph (5 µg/ml) associated or not 
with 5‑FU (50 µM) for 72 h. After removal of the medium, 2000 viable cells from each group were cultured in six‑well plates for additional 10 days. 
Colonies were stained with crystal violet. Each assay was photographed (a) and the number of colonies was analyzed and scored by Image J 
quantification software. Results are expressed as the number of colony forming cells per well and normalized to control (vehicle) in percentage and 
represented as mean ± SE of three independent experiments, each performed at least in duplicate (b). Asterisk represents a significant difference 
(*p < 0.05) as compared to no treatment group
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cell cultures and animal models [28]. The use of commer-
cially purified compounds based on their concentration 
and percentage in 5 µg/ml of Peph extract have indicated 
that the antiproliferative effect of Peph involves total 
polyphenolic compounds (Table 1). However, in the con-
text of our study, we still do not know which combination 
of compounds from the peel phenolic extract is behind 
the antiproliferative effect (Table 2; Additional file 1: Fig-
ure S1). Our data suggest that a synergistic effect between 
different molecules may have contributed to the antipro-
liferative effect of the Peph extract, on LS174 adenocar-
cinoma cells. This supports the fact that there are usually 
more benefits to use a whole natural plant extract, with 
different pharmacologically active phytochemicals, than 
a single isolated compound. Indeed, total compounds 
within Peph extract could inhibit any toxic effects of one 
compound alone and have many different intracellular 
targets, which may act in a synergistic way to enhance 
specific activity. Additionally, the presence of multiple 
components may possibly decrease the chances of devel-
oping chemoresistance [29]. Moreover, natural extracts 
like quince can be administered orally to patients, as a 
safe mode of administration. Many works have focused 
on the bioavailability and polyphenols bioefficacy in 
humans [30]. Polyphenol concentrations in the colon can 
reach several hundred micromoles per liter, and together 
with a few carotenoids, polyphenols constitute the only 
dietary present in the colon, because vitamins C and E 
are absorbed in the upper segments of the intestine [30, 
31].
Based on the fact that the total peel polyphenolic 
extract of Cydonia oblonga Miller is endowed with the 
potent antiproliferative activity against human colon 
carcinoma LS174 cells along with the cited biologi-
cal activities of its compounds, we tried to uncover the 
anticancer mechanisms of quince polyphenolic extract. 
Flow cytometry analysis showed an increase in the per-
centage of annexin-V positive cells when treated with 
quince Peph extract. Such apoptotic feature has been 
reported to be frequently associated with increased cas-
pases activity [32]. However, treatment with a pan-cas-
pase inhibitor (z-VAD-fmk) did not block the apoptotic 
cell death in Peph-treated LS174 cells. Furthermore, the 
Peph-induced apoptotic effect was not accompanied 
by processing of procaspase-3,-9, and PARP confirming 
that quince peel polyphenols induced LS174 cell apop-
tosis through a caspase-independent pathway. Endonu-
clease G (Endo G) and AIF are key factors, released by 
the mitochondria, that are able to induce a caspase-inde-
pendent apoptosis [33]. Interestingly, the quince Peph 
extract-induced apoptosis of LS174 cells was associated 
with an increase of AIF level but no effect was observed 
concerning Endo G expression level (Data not shown). 
Our result is in agreement with several studies report-
ing that various chemotherapeutic agents induced AIF-
mediated apoptosis in a large array of colon cancer cell 
lines [34]. Our data also correlate with a previous work 
done by Wang et al. [35] who reported that Berberine, an 
isoquinoline alkaloid derived from plants, induces cas-
pase-independent cell death in colon tumor cells through 
activation of AIF. This latter is also a Janus protein that 
directly regulates ROS production in the mitochondria 
[36]. In accordance with this, we investigated the poten-
tial of quince peel polyphenolic extract to modulate the 
intracellular amount of ROS. Interestingly, we observed 
an increase of ROS level after 24 and 72 h of treatment 
with Peph extract. This result suggests that the pro-apop-
totic effect of Peph extract may, at least in part, be caused 
by ROS production. Our data is in agreement with previ-
ous studies that reported a high level of ROS production 
in anti-cancer therapeutic strategies based on the activa-
tion of the AIF caspase-independent cell death [36].
Colon cancer has been also shown to be associated 
with an overexpression of growth promoting cell cycle 
regulators such as cyclin D1 [37]. An aberrant accu-
mulation of this regulator occurs in about one-third of 
colorectal cancer [38]. Interestingly, we found that Peph 
induced the downregulation of cyclin D1. This data sug-
gests that the antiproliferative effect of Peph phenolic 
extract pass through the inhibition of cyclin D1 expres-
sion, causing then the cell cycle arrest before the engage-
ment of tumor cells into an apoptotic cell death. Multiple 
signaling pathways such as Wnt/β-catenin, MAPK, PI3 K, 
JAKs/STAT3 and NF-κB signaling pathways are impli-
cated in colorectal cancer development [7, 39]. We have 
then explored the possible modulation, by Peph extract, 
of NF-κB, PI3  K/AKT and MAPK cascades pathways 
including ERK, JNK, and p38MAPKs. Analysis of the 
indicated pathways by western blot demonstrated that 
MAPK activity was not involved in the antiproliferative 
and apoptotic effect of Peph extract. These data are con-
sistent with those reported by Cho et al. [40] that found 
no involvement of the MAPK cascades in the caspase-
independent apoptosis of A172 glioma cells induced by 
15d-PGJ2. Our results also demonstrate that the PI3 K/
AKT survival pathway was not affected by Peph extract. 
However, Peph extract treatment of the LS174 cells inhib-
ited the NF-κB signaling pathway which is recognized 
as a key player in the initiation and propagation of CRC 
[11]. This data are also in accordance with a most recent 
review where authors reported that inhibition of the 
NF-κB signaling contributes to the anticancer effects of 
some therapeutic drugs to prevent colon cancer metasta-
sis [41]. These data also correlate with our previous work 
using THP-1-derived macrophages. Indeed, we reported 
that one way by which quince Peph extract inhibits 
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LPS-induced inflammation, is through the blockade of 
NF-κB activation [15]. NFκB orchestrates the expres-
sion of inflammatory cytokines, adhesion molecules and 
angiogenic factors [42]. Moreover, it has been shown that 
the inhibition of angiogenesis is mediated by the block-
ing of NFκB activation [22]. VEGF-A, the most impor-
tant regulator of tumor angiogenesis, is the first-choice 
target of anti-angiogenic therapies [43]. Clinical studies 
on patients with CRC suggest that VEGF-A expression 
is significantly higher in metastatic tumors than in non 
metastatic tumors, and the increased VEGF-A expression 
is related to the worse prognosis [41]. In accordance with 
this, we have then investigated the potential of quince 
Peph extract to modulate the expression and secretion of 
VEGF-A. Interestingly, we found that quince polyphenols 
inhibited VEGF-A gene expression, as assessed by Real-
Time quantitative PCR. We have also found that such 
effect was associated with a down-regulation of VEGF-A 
secretion. These data suggest that the inhibition effect, 
exerted by Peph extract on NFκB pathway caused the 
down-regulation of VEGF expression which may lead to 
the blocking of tumor-induced angiogenesis.
An understanding of the angiogenic pathways has 
progressed for the development of colorectal treatment 
[44]. Bevacizumab is a humanized monoclonal antibody 
which exerts its effect by inhibiting the effect of VEGF-
A thus inhibiting it’s binding to the VEGF receptor and 
prevents angiogenesis [45]. However, the indicated drugs 
suffer from being expensive for a larger use, besides they 
present several harmful side effects. Our results suggest 
that quince peel polyphenolic extract could represent 
an alternative since it has chemopreventive and chemo-
therapeutic properties through its dual inhibitory effect 
of both colon cancer cell survival/proliferation and angi-
ogenesis promoting molecules. Recent studies reported 
the promising possibilities of use of dietary compounds 
to sensitize tumors to chemotherapeutics agents [46]. 
Combinations of chemotherapeutical agents with sec-
ondary metabolites that have different modes of action 
can decrease the systemic toxicity because they allow 
lowering the concentrations of the most toxic therapeu-
tic drug [47]. We have then assessed the effect of quince 
Peph extract in combination to 5-Fluorouracil (5-FU), 
a classical anticancer drug recommended for first-line 
treatment in CRC [48]. Our result demonstrate that the 
combined treatment of 5-FU with Peph extract caused a 
significant decrease in colony formation of colon cancer 
cells compared to 5-FU alone. This finding suggest that 
quince Peph extract may improve the therapeutic effects 
of 5-Fluorouracil.
In the light of our study, quince peel polyphenolic 
extract, a natural product appears to be a promising 
potential anti-tumoral agent. Actually, natural products 
are the source of many drugs in cancer therapy and 
approximately 75 % of the approved anticancer therapies 
have been derived from natural products [49].
Conclusion
We highlighted an interesting pharmacological effect for 
peel polyphenolic extract of Cydonia oblonga Miller. We 
demonstrated for the first time that this extract induces 
proliferation arrest and apoptosis of colon cancer LS174 
cells and that such effect is at least partially mediated by 
inhibition of NF-κB activation. This extract also lowered 
VEGF-A expression and secretion by tumour cells which 
may lead to the inhibition of tumor-induced angiogen-
esis. We finally found that quince peel polyphenolic 
extract enhances the therapeutic activity of 5-Fluoroura-
cil in colon cancer LS174 cells.
It is worth to note that in our work this effect was due 
to total components of the phenolic extract that have 
acted synergistically to generate the potent anti-tumor 
effect. However, we must underline the importance of 
using the totem of quince peel polyphenols to benefit of 
its total bioactive compounds. Indeed, the studied extract 
is a non toxic natural food product that contains a mix-
ture of anti-tumor bioactive molecules that can poten-
tially be used alone or combined to the conventional 
chemotherapeutic agents used to treat colon cancer. 
Work is in progress to generate a 5-Fu-resistant LS174 
cell line model to study the effect of peel polyphenolic 
extract and potential synergistic interactions of its com-
pounds in this experimental system. Further investigation 
is also needed to better verify if the in vitro anti-tumour 
effect of quince polyphenols extract in human colon ade-
nocarcinoma LS174 cells can be extended to the in vivo 
setting. Detailed pharmacokinetic and toxicological stud-
ies with experimental animals are required before such a 
strategy can be translated into clinical practice.
Methods
Quince polyphenols extraction
Quince polyphenols preparations along with identifica-
tion and quantification of their compounds using high-
performance liquid chromatography with diode-array 
detection (HPLC–DAD) coupled on line to a mass spec-
trometer (MS) were performed as previously reported 
[13, 15]. The thirteen identified pure compounds present 
in the quince peel polyphenolic extract (Peph) (Querce-
tin (Q), Rutin (R), (+)-Catechin (+C), (−)-Catechin 
(−C), Hyperin (H), Isoquercitrin (I), Chlorogenic acid 
(ChA), Cryptochlorogenic acid (CrA), Neochlorogenic 
acid (NeA), p-coumaric acid (PcA), Kaempferol (K), 
Kaempferol-3-O-glucoside(K3g) and Kaempferol-3-O-
rutinoside (K3r)) were purchased from Sigma (Sigma, 
Aldrich).
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Cell culture and treatment
Human colon adenocarcinoma LS174 cell line (CL-188), 
and non-tumourigenic cells human embryonic kidney 
HEK293 (CRL1573) and mouse embryonic fibroblasts 
NIH3T3 (CRL-1658) were obtained from American Type 
Culture Collection (ATCC, Manassas, VA). The cells 
were cultured in DMEM (Dulbecco’s Modified Eagle’s 
Medium) supplemented with 10  % fetal bovine serum 
(FBS; GIBCO) and 50 U/ml penicillin and 50 µg/ml strep-
tomycin. Cells were seeded with an adequate cell density 
and treated with different concentrations of quince poly-
phenolic extract in triplicate and incubated for 24, 48 and 
72 h.
Measurement of cell viability
Cell viability was determined with colorimetric MTT 
(3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl tetrazolium 
bromide) assay. The non-tumourigenic HEK293 and 
NIH3T3 cells and human colon adenocarcinoma LS174 
cells were seeded in 96-well plates (1000 cells/well). 
After 24  h, the cells were treated with serial concentra-
tions of quince polyphenolic extracts (1, 2.5, 5, 10, 15 
and 20  µg/ml) or pure phenolic compounds at equiva-
lent concentrations to that present in 5 µg/ml of Peph for 
various periods (24, 48 and 72 h). In this assay, a color-
less tetrazolium salt (MTT) is cleaved and converted to 
blue formazan by the mitochondrial dehydrogenase in 
living cells. Thereafter, 50  µl of a MTT solution (1  mg/
ml final) was added into each 96-well plate, and the cells 
were incubated for a further 3 h at 37 °C, 100 µl of DMSO 
was added to each well to dissolve the blue formazan. 
The optical density (OD) at 540 nm was measured with 
a microplate reader (MULTISKAN, Labsystems). The 
cell viability was expressed as percentage of the viable 
cell number in treated cells relative to mock-treated cells 
(control). Cell viability was calculated using the following 
formula: % cell viability = ODtest/ODcontrol × 100.
LDH release assay
Cellular membrane integrity was monitored by the per-
meability assay based on the release of lactate dehy-
drogenase (LDH) into the media. LDH release from 
non-tumourigenic cells HEK293, NIH 3T3 and Human 
colon adenocarcinoma LS174 cells was determined by 
using the LDH Cytotoxicity Detection Kit-PLUS test 
(Roche Applied Science, Mannheim, Germany) according 
to the manufacturer’s protocol. Briefly, cells were seeded 
in 12-well plates (105cells/well) and cultured for 72 h with 
different concentrations (5, 10 and 20  µg/ml) of quince 
polyphenolic extracts (Peph and Puph). The percentage 
release of LDH was calculated from the treated cells by 
comparing it with the maximum release obtained by 1 % 
Triton X-100 treatment (positive control) and the spon-
taneous LDH release (mock-treated cells considered as a 
negative control) as follows: Cytotoxicity (%) =  (experi-
mental value–negative control)/(positive control–nega-
tive control) × 100.
Cell cycle phase distribution analysis
LS 174 cells were seeded into six-well plates at a density 
of 2  ×  105 cells/ml, grown for 24  h and then exposed 
for 24 and 72  h to 5  µg/ml of quince peel polyphenolic 
extract (Peph). Thereafter, cells were collected by cen-
trifugation at 1000  rpm, washed twice with 1X ice-cold 
PBS containing 2 % bovine albumin serum (BSA) (Sigma) 
and resuspended in Hypertonic solution (20 mM HEPES, 
pH 7.2; 0.16 M NaCl; 1 mM EGTA; 0.05 % Triton X-100). 
After incubation at 4 °C, cells were washed, treated with 
propidium iodide (PI)/RNase staining solution (Cell 
Signaling Technology; Danvers, MA) and incubated for 
at least 30 min in the dark at 37  °C. Cell cycle distribu-
tion profiles were analyzed on a Becton–Dickinson FAC-
Scanto II flow cytometer and further analyzed with BD 
FACSDiva 6 software (Becton–Dickinson). The PI fluo-
rescence signal at FL2-A peak versus counts was used to 
determine cell cycle distribution and the data were ana-
lyzed using the Modfit software. The percentage of cells 
in SubG0, G0/G1, S and G2/M was determined.
Apoptosis detection
Detection and quantification of apoptosis was performed 
by the analysis of phosphatidylserine on the outer leaflet 
of apoptotic cell membranes using annexin V/PE apop-
tosis detection kit (BD-Pharmingen) according to the 
manufacturer’s protocol. Approximately 105 cells, treated 
with 5 µg/ml of Peph for 24 and 72 h or vehicle as a nega-
tive control were collected by centrifugation, and washed 
with PBS (1×). For caspase inhibitor activity assay, 
cells were pre-incubated with a pan-caspase inhibitor, 
Z-VAD-FMK (20  µM) (BD Pharmingen) for 2  h before 
Peph-treatment. LS174 cells were resuspended in 100 μl 
of binding buffer (1×) before addition of 4 μl of Annexin 
V conjugated to phycoerythrin (PE) and 4 µl of 7-AAD. 
The cell suspension was incubated in the dark rapidly for 
15  min. Stained cells were analyzed on a Becton–Dick-
inson FACScanto II flow cytometer and further analyzed 
with BD FACSDiva 6 software (Becton–Dickinson). 
Cell death was quantitatively evaluated by measuring 
the proportion of annexin V-positive cells, regardless of 
their staining for 7-AAD in order to include both apop-
totic and necrotic cell death. Values are given in percent 
of total cell number. Percentage of apoptotic cells (%) 
was calculated as follows: early apoptotic cells (%) + late 
apoptotic cells (%).
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Measurement of reactive oxygen species (ROS)
The intracellular level of ROS was determined using a 
cell-permeable fluorogenic probe, CMH2DCF-DA (life 
technologies, Oregon, USA). This molecule passively 
diffuses into cells, where its acetate groups are cleaved 
by intracellular esterases and its thiol-reactive chloro-
methyl group reacts with intracellular glutathione and 
other thiols. Subsequent oxidation yields a fluorescent 
adduct in the presence of ROS. LS174 cells were seeded 
in 96-well plates (2000 cells/well) and treated with 5 µg/
ml of Peph for 24 and 72 h. Cells were washed with PBS 
(1×), resuspended in HBSS (GIBCO) and incubated 
with CMH2DCFDA (10 µM) at 37 °C for 30 min in dark. 
Fluorescence was detected with excitation and emission 
wavelength at 492 and 517 nm respectively.
Western blot analysis
At various times (24, 48 and 72  h) after 5  µg/ml of 
peel polyphenols treatment, the LS174 cells were col-
lected and lysed at room temperature with 100  µl of 
Laemmli buffer (1×). Protein content of the cell lysates 
was quantified using the BCA method (Bicinchoninic 
Acid Protein Assay kit, Sigma). Equal amounts of pro-
tein (30 µg/sample) were separated electrophoretically 
by 10  % SDS-PAGE and blotted onto PVDF mem-
branes (Immobilon-Millipore). The blots were probed 
with primary antibodies and incubated with a horse-
radish peroxidase-conjugated anti-IgG in a blocking 
buffer for 1 h. Primary antibodies anti-phospho-AKT, 
anti-AKT, anti-ERK2, anti-phospho-JNK/SAPK, anti-
JNK/SAPK, anti-phospho-p38, anti-phospho-IKKα/β, 
anti-IKKα, anti-PARP, anti-caspase 9, anti-caspase 3, 
anti-AIF, anti-Cyclin D1 and loading control anti-actin 
were from cell Signaling Technology (Danvers, MA, 
USA). Anti-phospho ERKs were from Sigma-Aldrich 
(L’Isle d’Abeau, Chesnes, France), and anti-horserad-
ish peroxidase-conjugated anti-mouse and anti-rabbit 
antibodies were from Promega (Madison, WI). After 
washing, the blots were developed with enhanced 
chemiluminescence (ECL) (Millipore) and exposed to 
X-ray film.
Real time quantitative RT‑PCR
To evaluate the expression patterns of up-regulated or 
down-regulated genes after 5  µg/ml of peel polyphe-
nols (Peph) treatment, the selected genes were chosen 
for further analysis using real-time quantitative reverse 
transcription-PCR (RTQ-RT-PCR) in a 96-well format. 
Real-time PCR measures of VEGF-A cDNA expression 
were obtained using a Light Cycler with a Fast Start DNA 
Master Mix SYBR Green. The 2[−ΔΔC (T)] method was 
used to calculate the relative expression of gene, as previ-
ously described [50].
Determination of cytokine concentrations
Cell culture supernatants from LS174 cells treated with 
5 µg/ml of peel polyphenolic extract (Peph) for 72 h were 
collected centrifuged at 10,000  rpm for 5  min and the 
cells were counted. Determination of the VEGF-A con-
centrations was carried out using an ELISA kit Quan-
tikine human VEGF Immunoassay (Pierce, Rockford, 
USA) following the manufacturer’s guidelines and nor-
malized to cell number.
Colony formation assay
For clonogenic assays, LS174 cells were plated in six-well 
plates (2 ×  105cells/well) and treated the day after with 
5  µg/ml of peel polyphenolic extract alone or in com-
bination with 50  μM of 5-Fluorouracil for a period of 
72 h. After removal of the medium containing antitumor 
drugs, cells were trypsinized and plated at low density 
(2000 cells per six-well plate). Cells were then cultivated 
for 10 days. Colonies were stained with crystal violet and 
clones for each condition were scored by Image J quanti-
fication software. Results are expressed as the number of 
colony forming cells per well and normalized to control 
(vehicle) in percentage (considered to represent 100 %).
Statistical analysis
Data from individual experiments are expressed as 
mean ±  SE. Differences between means were evaluated 
using Student’s t test. Differences with p values of less 
than 0.05 were considered statistically significant.
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